Clinical Trial Update: Long-Term Lamivudine Therapy for Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating long-term lamivudine therapy for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Epivir-HBV (lamivudine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED